SCHEMBL24193439

SCHEMBL24193439

O=C1NC(=O)C(c2ccccc2)(c2ccc([N+](=O)[O-])cc2)N1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.69
▸ ALDH1A1 P00352 3/20 0.69
▸ CYP2C9 P11712 2/20 0.69
▸ CACNA1F O60840 1/20 0.69
▸ HTR2A P28223 1/20 0.69
▸ HRH1 P35367 1/20 0.69
▸ SCN1A P35498 1/20 0.69
▸ SCN4A P35499 1/20 0.69
▸ BLM P54132 1/20 0.69
▸ PMP22 Q01453 1/20 0.69
▸ CACNA1D Q01668 1/20 0.69
▸ KCNH2 Q12809 1/20 0.69
▸ CACNA1S Q13698 1/20 0.69
▸ CACNA1C Q13936 1/20 0.69
▸ SCN5A Q14524 1/20 0.69
▸ SCN2A Q99250 1/20 0.69
▸ SCN3A Q9NY46 1/20 0.69
▸ AKR1B1 P15121 3/20 0.62
▸ LMNA P02545 2/20 0.46
▸ MMP2 P08253 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27233049 0.94 ALDH1A1 (0.56) MAPTALDH1A1CYP2C9CACNA1FHTR2A
SCHEMBL24193557 0.87 CYP2C9 (0.63) MAPTALDH1A1CYP2C9CACNA1FHTR2A
Phenytoin SCHEMBL5499612 0.83 CYP2C9 (1.00) MAPTALDH1A1CYP2C9CACNA1FHTR2A
Phenytoin SCHEMBL3440 0.83 CYP2C9 (1.00) MAPTALDH1A1CYP2C9CACNA1FHTR2A
Phenytoin SCHEMBL2140317 0.81 CYP2C9 (0.96) MAPTALDH1A1CYP2C9CACNA1FHTR2A
Phenytoin SCHEMBL1461588 0.81 CYP2C9 (0.96) MAPTALDH1A1CYP2C9CACNA1FHTR2A
Phenytoin SCHEMBL157671 0.81 CYP2C9 (0.96) MAPTALDH1A1CYP2C9CACNA1FHTR2A
Phenytoin SCHEMBL2905857 0.81 CYP2C9 (0.96) MAPTALDH1A1CYP2C9CACNA1FHTR2A
Phenytoin SCHEMBL10406406 0.81 CYP2C9 (0.96) MAPTALDH1A1CYP2C9CACNA1FHTR2A
Phenytoin SCHEMBL5160618 0.81 CYP2C9 (0.96) MAPTALDH1A1CYP2C9CACNA1FHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11655203-B2 Nitration ETH ZURICH (CH) 2023-05-23 — — US disclosed
US-20220009875-A1 NITRATION ETH ZURICH (CH) 2022-01-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220009875-A1 NITRATION NOS1, NOS2, NOS3 MAPT 3137/4885ALDH1A1 2335/4885CYP2C9 117/4885
US-11655203-B2 Nitration NOS1, NOS2, NOS3 MAPT 3137/4885ALDH1A1 2335/4885CYP2C9 117/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback